MINIMAL RESIDUAL DISEASE BY MULTIPARAMETER FLOW CYTOMETRY IN TRANSPLANT ELIGIBLE PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA: RESULTS FROM THE EMN02/HO95 PHASE 3 TRIALS. Oliva,D. Hofste Op Bruinink,L. Rihova,S. Spada,B. van der Holt,R. Troia,M. Gambella,L. Pantani,S. Grammatico,M. Gilestro,M. Offidani,R. Ribolla,M. Galli,R. Hajek,A. Palumbo,M. Cavo, P. Omede,V. van der Velden, M. Boccadoro,P. SonneveldHAEMATOLOGICA（2017）引用 0|浏览5暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
